Harmony Biosciences Holdings
HRMY
$38.27+2.03%
End of day · as of Oct 16, 2026, 8:01 AM ET
Mkt cap
$1.96B
EV/Sales
1.57
P/E ratio
12.4
FY2025 Revenue
$868.45M
EPS (TTM)
$3.09
Gross Margin (FY2025)
77.16%
Profit Margin (FY2025)
18.27%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Harmony Biosciences Holdings (HRMY) is a biotechnology company listed on NASDAQ.
Latest reported HRMY revenue for 2025-12-31 was $868.5M. Net income was $158.7M. Revenue was up 21.5% from 2024-12-31 to 2025-12-31. HRMY currently screens at market cap $1.96B and trailing P/E 12.4.
Use this HRMY research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full HRMY income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Harmony Biosciences Holdings (HRMY) is a biotechnology company in the Healthcare sector.
Latest cached Harmony Biosciences Holdings (HRMY) revenue for Dec 31, 2025 was $868.5M. Net income was $158.7M. Statements: https://lician.com/financials/hrmy
Harmony Biosciences Holdings (HRMY) trailing P/E is 12.4 on the latest cached fundamentals snapshot.
Harmony Biosciences Holdings (HRMY) market capitalization is $1.96B on the latest cached snapshot.
Harmony Biosciences Holdings (HRMY) cached previous close $37.51; day range $38.04 – $38.27; volume 790,662. Session quote: https://lician.com/quote/hrmy
Harmony Biosciences Holdings (HRMY) latest cached earnings event is "HRMY earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached HRMY filing is 8-K · Oct 13, 2026. Filings: https://lician.com/sec/hrmy